MedPath

The possibility of IL-36 cytokines as a novel biomarker of the severity and mortality in the patients with bacteremia or sepsis.

Not Applicable
Conditions
Bacteremia and Sepsis
Registration Number
JPRN-UMIN000033513
Lead Sponsor
Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1) The person who are under 20 years old (2) Pregnancy (3) The person whom we can not obtain the informed consent. (4) Not appropriate as a physician's judgement

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The production of IL-36 cytokines Severity and mortality
Secondary Outcome Measures
NameTimeMethod
Extracellular microvesicles
© Copyright 2025. All Rights Reserved by MedPath